Decision Aid for Dementia

Overseen By Caylyn Rich, MSc

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Colorado, Denver

Disqualifiers: Moderate dementia, Severe dementia, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

100 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to develop a decision aid to support patients and families making decisions about medications for dementia.

Who Is on the Research Team?

Dan Matlock, MD, MPH

Principal Investigator

University of Colorado, Denver

Are You a Good Fit for This Trial?

This trial is for UCHealth patients aged 60 or older with mild cognitive impairment or early dementia, as well as their caregivers and healthcare providers involved in dementia care. Participants must speak English or Spanish.

Inclusion Criteria

I am over 18, have memory problems as diagnosed by my doctor, and speak English or Spanish.

My caregiver is over 18 and speaks English or Spanish.

I am a healthcare professional involved in dementia care and speak English or Spanish.

Exclusion Criteria

I am a clinician who does not speak English or Spanish.

Patients who are not English or Spanish-speaking, have neurocognitive deficits suggestive of moderate or severe cognitive impairment or late-stage dementia, or are not able to consent for themselves

My caregiver is under 18 or doesn't speak English/Spanish.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Development

Development of a decision aid based on international standards and user-centered design

11 months

Qualitative Assessment

Conduct a qualitative decision needs assessment of pharmacologic therapies for dementia

11 months

Pilot Feasibility

Pilot study to determine the feasibility and acceptability of a decision aid

12 months

Follow-up

Participants are monitored for safety and effectiveness after the intervention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Decision Aid

Trial Overview The study aims to create a decision aid tool to help patients with dementia and their families decide on medication treatments. It involves patients, their primary support person, and healthcare professionals.

How Is the Trial Designed?

Group I: Decision Aid Experimental Treatment 1 Intervention

Participants provide feedback on the development of a decision aid for dementia therapies.

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials

1,842

Recruited

3,028,000+

National Institute on Aging (NIA)

Collaborator

Trials

1,841

Recruited

28,150,000+